World’s Largest Enzyme Producer Will Reveal Details on Cellulosic Ethanol Technology
--(BUSINESS WIRE)--Novozymes (Copenhagen: NZYM B):
Who: | Steen Riisgaard, CEO, Novozymes | |
What: | Novozymes CEO to discuss advancements of commercial viability of cellulosic ethanol | |
When: |
Tuesday, February 16, 7:15 – 8:00 a.m. EST |
|
Where: | National Ethanol Conference, Gaylord Palms Resort and Convention Center | |
6000 W Osceola Parkway, Kissimmee, FL 34746 | ||
NEC Press Room – Gainesville 1 | ||
(407) 586-0000 | ||
Live audio/video webcast available at: | ||
http://www.novozymes.com/en/MainStructure/PressAndPublications/ or |
||
Why: |
To announce a technological breakthrough for cellulosic ethanol |
|
Video: | Novozymes B-roll will be available via satellite feed in the U.S. at the following coordinates below. (All other regions may request video from their corresponding media contact listed below): | |
Tuesday, February 16th, 2010 | ||
10:00AM – 10:15 AM EST |
||
Galaxy 19 | ||
C-Band | ||
Transponder 8 | ||
Downlink Freq: 3860 Horizontal | ||
Photos: |
A selection of photos to accompany the announcement will be made available by request from media contacts listed below. |
|
|
About Novozymes:
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow’s industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace. Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature’s potential is evidenced by over 5,000 patents, showing what is possible when nature and technology join forces. Our 5,200+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow. Novozymes is quoted on OMX Nordic Exchange Copenhagen A/S (NZYM B). Read more at www.novozymes.com.
Contacts
Novozymes
Media relations:
U.S.
Paige Donnelly, 919-494-3209
Mobile: 919-218-4501
pagd@novozymes.com
or
Europe
Rene Tronberg, +45 4446 2274
Mobile: +45 3077 2274
retr@novozymes.com
or
Annegrethe Jakobsen, +45 4446 3050
Mobile: +45 3077 3050
agmj@novozymes.com
or
Johan Melchior, +45 4446 0690
Mobile: +45 3077 0690
jmel@novozymes.com
or
China
Zhu Xiaoqing, +86 1380 124 0590
Mobile: +86 1062 981283
xqzh@novozymes.com
or
Brazil
Saio Ribeiro de Paula, +55 41 3641 1112
Mobile: +55 41 9971 7225
saio@novozymes.com